Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07346014 · ClinicalTrials.gov registry record · NA
Sleep and Circadian Interventions for College Students at High Risk of Suicide
A NA study, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT07346014: Recruiting NA study, sponsored by University of Pittsburgh.
NCT07346014 is a NA study that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07346014, a NA study, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the extent to which delivering sleep and circadian focused interventions in addition to evidenced based psychiatric care for depression and suicide risk may contribute to decreasing suicide risk among high risk young adults. Investigators will evaluate three interventions targeting sleep in acutely suicidal college students enrolled in intensive outpatient treatment. Participants will be randomly assigned to one of three intervention groups: 1. Triple Chronotherapy (TCT)+ Transdiagnostic Sleep and Circadian Intervention (TSC) 2. Transdiagnostic Sleep and Circadian Intervention (TSC) 3. Sleep Feedback (SF) Participants will be followed for 6 months with primary outcome domains of suicidal thoughts and behaviors and depression evaluated by blinded clinicians at short (Days 1-4 of intervention), medium (2 months) and long (6 month) term intervals.
Primary Outcome
Columbia Suicide Severity Rating Scale, administered via clinician on Intervention Days 1-4. Range of 0-5, higher values represent higher severity/intensity
Interventions
- BEHAVIORAL Sleep Feedback + Psychoeducation
- BEHAVIORAL Transdiagnostic Sleep and Circadian Intervention + Bright Light (TSC+)
- BEHAVIORAL Triple Chronotherapy (TCT+)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2026-06-18 |
| Est. Completion | 2029-03 |
| Phase | NA |
What NCT07346014 shows while recruiting
NCT07346014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Sleep Feedback + Psychoeducation is the first listed.
NCT07346014 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07346014 about?
NCT07346014 is a clinical study titled "Sleep and Circadian Interventions for College Students at High Risk of Suicide". The purpose of this study is to examine the extent to which delivering sleep and circadian focused interventions in addition to evidenced based psychiatric care for depression and suicide risk may contribute to decreasing suicide risk among high risk young adults. Investigators will evaluate three i...
What is the current status of trial NCT07346014?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2026-06-18. Estimated completion is 2029-03.
What interventions are being tested in trial NCT07346014?
The interventions under investigation include: Sleep Feedback + Psychoeducation (BEHAVIORAL), Transdiagnostic Sleep and Circadian Intervention + Bright Light (TSC+) (BEHAVIORAL), Triple Chronotherapy (TCT+) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07346014?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07346014's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI